Medicenna Therapeutics Net Debt Growth & History (MDNAF)
Medicenna Therapeutics's net debt was −$6.1M for fiscal 2026.
View full Medicenna Therapeutics company overviewMedicenna Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$6.1M | $18.5M | — |
| 2025 | 2025-03-31 | −$24.7M | −$7.7M | — |
| 2024 | 2024-03-31 | −$17.0M | $16.6M | — |
| 2023 | 2023-03-31 | −$33.6M | −$13.1M | — |
| 2022 | 2022-03-31 | −$20.5M | $9.8M | — |
| 2021 | 2021-03-31 | −$30.3M | −$7.7M | — |
| 2020 | 2020-03-31 | −$22.6M | — | — |
Medicenna Therapeutics quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | −$5.6M | $14.7M | — |
| Q4 2026 | 2026-03-31 | −$6.1M | $18.5M | — |
| Q3 2026 | 2025-12-31 | −$10.5M | — | — |
| Q2 2026 | 2025-09-30 | −$15.6M | — | — |
| Q1 2026 | 2025-06-30 | −$20.3M | — | — |
| Q4 2025 | 2025-03-31 | −$24.7M | — | — |
| Q4 2023 | 2023-03-31 | −$33.6M | −$13.1M | — |
| Q4 2022 | 2022-03-31 | −$20.5M | $9.8M | — |
| Q4 2021 | 2021-03-31 | −$30.3M | — | — |
Medicenna Therapeutics net debt trends
Over the last five fiscal years, Medicenna Therapeutics's net debt increased from −$30.3M to −$6.1M, a change of $24.2M. The latest reported quarter, Q1 2027, shows −$5.6M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicenna Therapeutics source filings ↗